Authors: Dormer, RL McNeilly, CM Morris, MR Pereira, MMC Doull, IJM Becq, F Mettey, Y Vierfond, JM McPherson, MA

Citation: Rl. Dormer et al., Localisation of wild-type and Delta F508-CFTR in nasal epithelial cells, PFLUG ARCH, 443, 2001, pp. S117-S120

Authors: McPherson, MA Pereira, MMC Russell, D McNeilly, CM Morris, RM Stratford, FLL Dormer, RL

Citation: Ma. Mcpherson et al., The CFTR-mediated protein secretion defect: pharmacological correction, PFLUG ARCH, 443, 2001, pp. S121-S126

Authors: Dormer, RL Derand, R McNeilly, CM Mettey, Y Bulteau-Pignoux, L Metaye, T Vierfond, JM Gray, MA Galietta, LJV Morris, MR Pereira, MMC Doull, IJM Becq, F McPherson, MA

Citation: Rl. Dormer et al., Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells, J CELL SCI, 114(22), 2001, pp. 4073-4081

Authors: Bulteau, L Derand, R Mettey, Y Metaye, T Morris, MR McNeilly, CM Folli, C Galietta, LJV Zegarra-Moran, O Pereira, MMC Jougla, C Dormer, RL Vierfond, JM Joffre, M Becq, F

Citation: L. Bulteau et al., Properties of CFTR activated by the xanthine derivative X-33 in human airway Calu-3 cells, AM J P-CELL, 279(6), 2000, pp. C1925-C1937

Authors: Becq, F Mettey, Y Gray, MA Galietta, LJV Dormer, RL Merten, M Metaye, T Chappe, V Marvingt-Mounir, C Zegarra-Moran, O Tarran, R Bulteau, L Derand, R Pereira, MMC McPherson, MK Rogier, C Joffre, M Argent, BE Sarrouilhe, D Kammouni, W Figarella, C Verrier, B Gola, M Vierfond, JM

Citation: F. Becq et al., Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel, J BIOL CHEM, 274(39), 1999, pp. 27415-27425

Authors: McPherson, MA Pereira, MMC Mills, CL Murray, KJ Dormer, RL

Citation: Ma. Mcpherson et al., A cyclic nucleotide PDE5 inhibitor corrects defective mucin secretion in submandibular cells containing antibody directed against the cystic fibrosistransmembrane conductance regulator protein, FEBS LETTER, 464(1-2), 1999, pp. 48-52